	营业费用		日
Akebia Therapeutics	USD 63.08M	8.26M	2025-12
Alaunos Therapeutics	USD 1.01M	175K	2026-03
Avita Medical	AUD 28.02M	1.55M	2025-12
Clinuvel Pharmaceuticals	AUD 23.42M	6.49M	2025-12
Dianthus Therapeutics	USD 47M	22.83M	2026-03
Genetic Signatures	AUD 17.52M	9.22M	2025-12
Ionis Pharmaceuticals	USD 370.24M	6.24M	2026-06
Medical Developments International	AUD 21.61M	11.59M	2025-12
Neuren Pharmaceuticals	AUD 25.23M	16.54M	2025-12
Organon & Co	USD 1.01B	103M	2026-06
Paradigm Biopharmaceuticals	AUD 21.85M	13.36M	2025-12
PYC Therapeutics	AUD 33.63M	14.33M	2025-12
Starpharma Holdings	AUD 11.7M	7.69M	2025-12
Tectonic Therapeutic	USD 27.3M	5.78M	2026-03
Telix Pharmaceuticals	AUD 430.99M	25.59M	2026-06
Viatris	USD 3.68B	145.9M	2026-06
Xeris Pharmaceuticals	USD 75.21M	6.18M	2026-03